ZYLOXTB buys back 51,000 H shares; treasury stock reaches 9.25 million

Bulletin Express05-14

Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a next-day return confirming the on-market repurchase of 51,000 H shares on 14 May 2026.

• Repurchase details – Price range: HKD 21.68–22.20 per share – Volume-weighted average price: HKD 22.03 – Aggregate consideration: HKD 1.12 million

• Capital structure after the transaction – Issued shares (excluding treasury): reduced from 327.15 million to 327.10 million, a 0.0152 % decrease – Treasury shares: increased from 9.20 million to 9.25 million – Total issued shares (including treasury): unchanged at 336.35 million

• Repurchase mandate utilisation – General mandate granted on 13 May 2026 permits repurchase of up to 32.72 million shares – Cumulative buybacks under the mandate: 102,000 shares, representing 0.0305 % of issued shares on the mandate date – Moratorium on new share issues or treasury share sales runs through 13 June 2026

The company confirmed all regulatory requirements and listing rules were observed in executing the repurchase, and all bought-back shares have been designated as treasury shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170470733?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170470733","market":"hk","top_or_hot":-1,"title":"ZYLOXTB buys back 51,000 H shares; treasury stock reaches 9.25 million","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a next-day return confirming the on-market repurchase of 51,000 H shares on 14 May 2026.</p>\n<p>• Repurchase details  \n  – Price range: HKD 21.68–22.20 per share  \n  – Volume-weighted average price: HKD 22.03  \n  – Aggregate consideration: HKD 1.12 million</p>\n<p>• Capital structure after the transaction  \n  – Issued shares (excluding treasury): reduced from 327.15 million to 327.10 million, a 0.0152 % decrease  \n  – Treasury shares: increased from 9.20 million to 9.25 million  \n  – Total issued shares (including treasury): unchanged at 336.35 million</p>\n<p>• Repurchase mandate utilisation  \n  – General mandate granted on 13 May 2026 permits repurchase of up to 32.72 million shares  \n  – Cumulative buybacks under the mandate: 102,000 shares, representing 0.0305 % of issued shares on the mandate date  \n  – Moratorium on new share issues or treasury share sales runs through 13 June 2026</p>\n<p>The company confirmed all regulatory requirements and listing rules were observed in executing the repurchase, and all bought-back shares have been designated as treasury shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZYLOXTB buys back 51,000 H shares; treasury stock reaches 9.25 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZYLOXTB buys back 51,000 H shares; treasury stock reaches 9.25 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-14 18:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a next-day return confirming the on-market repurchase of 51,000 H shares on 14 May 2026.</p>\n<p>• Repurchase details  \n  – Price range: HKD 21.68–22.20 per share  \n  – Volume-weighted average price: HKD 22.03  \n  – Aggregate consideration: HKD 1.12 million</p>\n<p>• Capital structure after the transaction  \n  – Issued shares (excluding treasury): reduced from 327.15 million to 327.10 million, a 0.0152 % decrease  \n  – Treasury shares: increased from 9.20 million to 9.25 million  \n  – Total issued shares (including treasury): unchanged at 336.35 million</p>\n<p>• Repurchase mandate utilisation  \n  – General mandate granted on 13 May 2026 permits repurchase of up to 32.72 million shares  \n  – Cumulative buybacks under the mandate: 102,000 shares, representing 0.0305 % of issued shares on the mandate date  \n  – Moratorium on new share issues or treasury share sales runs through 13 June 2026</p>\n<p>The company confirmed all regulatory requirements and listing rules were observed in executing the repurchase, and all bought-back shares have been designated as treasury shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1170470733","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170470733","pubTimestamp":1778755449,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a next-day return confirming the on-market repurchase of 51,000 H shares on 14 May 2026. • Repurchase details     – Price range: HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"ZYLOXTB回购5.1万股H股；库存库存达到925万","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a next-day return confirming the on-market repurchase of 51,000 H shares on 14 May 2026.\n• Repurchase details  \n  – Price range: HKD 21.68–22.20 per share  \n  – Volume-weighted average price: HKD 22.03  \n  – Aggregate consideration: HKD 1.12 million\n• Capital structure after the transaction  \n  – Issued shares (excluding treasury): reduced from 327.15 million to 327.10 million, a 0.0152 % decrease  \n  – Treasury shares: increased from 9.20 million to 9.25 million  \n  – Total issued shares (including treasury): unchanged at 336.35 million\n• Repurchase mandate utilisation  \n  – General mandate granted on 13 May 2026 permits repurchase of up to 32.72 million shares  \n  – Cumulative buybacks under the mandate: 102,000 shares, representing 0.0305 % of issued shares on the mandate date  \n  – Moratorium on new share issues or treasury share sales runs through 13 June 2026\nThe company confirmed all regulatory requirements and listing rules were observed in executing the repurchase, and all bought-back shares have been designated as treasury shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170470733","isCrawlerRequest":true}